GLSI
Greenwich Lifesciences Inc
NASDAQ: GLSI · HEALTHCARE · BIOTECHNOLOGY
$21.60
-5.26% today
Updated 2026-04-29
Market cap
$332.37M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$8 – $34
Volume
0.2M
Greenwich Lifesciences Inc (GLSI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-543.00%
ROA
-254.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-1.57M | — | — | — |
| 2018 | $0.00 | $-1.69M | — | — | — |
| 2019 | $0.00 | $-3.43M | — | — | — |
| 2020 | $0.00 | $-1.86M | — | — | — |
| 2021 | $0.00 | $-4.57M | — | — | — |
| 2022 | $0.00 | $-7.83M | — | — | — |
| 2023 | $0.00 | $-8.89M | — | — | — |
| 2024 | $0.00 | $-15.79M | — | — | — |